Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Inventory (2018 - 2026)

Profound Medical has reported Inventory over the past 8 years, most recently at $8.2 million for Q4 2025.

  • For Q4 2025, Inventory rose 42.01% year-over-year to $8.2 million; the TTM value through Dec 2025 reached $8.2 million, up 42.01%, while the annual FY2025 figure was $8.2 million, 42.01% up from the prior year.
  • Inventory for Q4 2025 was $8.2 million at Profound Medical, down from $8.3 million in the prior quarter.
  • Over five years, Inventory peaked at $7.8 billion in Q1 2022 and troughed at -$2.1 million in Q2 2021.
  • A 5-year average of $394.3 million and a median of $6.8 million in 2024 define the central range for Inventory.
  • Biggest five-year swings in Inventory: tumbled 142.9% in 2021 and later surged 362952.58% in 2022.
  • Year by year, Inventory stood at $7.4 million in 2021, then rose by 7.12% to $7.9 million in 2022, then fell by 11.99% to $7.0 million in 2023, then dropped by 17.0% to $5.8 million in 2024, then skyrocketed by 42.01% to $8.2 million in 2025.
  • Business Quant data shows Inventory for PROF at $8.2 million in Q4 2025, $8.3 million in Q3 2025, and $8.4 million in Q2 2025.